High Court finds patent for asthma treatment invalid | Practical Law
The High Court has found that a patent owned by AstraZeneca for the treatment of asthma was obvious in light of a prior art patent and the common general knowledge. (Teva UK Ltd and another v AstraZeneca AB [2014] EWHC 2873 (Pat), 2 September 2014.)